LifeStance reports Q4 revenue $325.5M, consensus $313.96M

“The team delivered exceptional performance in 2024,” said CEO Ken Burdick. “We grew revenue 19%, more than doubled Adjusted EBITDA, and generated strong Free Cash Flow of $86M. We have delivered consistently strong financial and operational performance over the last two years, and have begun to demonstrate the true potential of LifeStance (LFST). Looking ahead to 2025, we feel we are well-positioned to continue our strong momentum while delivering on our mission of expanding access to affordable, high quality mental healthcare.”